OTC · CIK 0001826892
BCAB BioAtla, Inc.
Insider trading from SEC Form 4. Last filing 40 d ago.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
10
with a Form 4 at this company
Signals
Open-market buys and sells at BioAtla, Inc., scored.
No scored open-market trades yet. Grants, exercises and other rows are below.
Transactions
The last 25 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 31, 2026 | Jay M Short Phd Chief Executive Officer | FTax withholding Common Stock | -259 | $1.69 | $438 | 52,035 | 40 d ago |
| Aug 31, 2026 | Eric Sievers Chief Medical Officer | FTax withholding Common Stock | -134 | $1.69 | $226 | 11,346 | 40 d ago |
| Aug 31, 2026 | Christian Vasquez Chief Financial Officer | FTax withholding Common Stock | -71 | $1.69 | $120 | 10,476 | 40 d ago |
| Aug 31, 2025 | Richard A Waldron Chief Financial Officer | FTax withholding Common Stock | -2,371 | $0.46 | $1,080 | 338,521 | Sep 2, 2025 |
| Aug 31, 2025 | Eric Sievers Chief Medical Officer | FTax withholding Common Stock | -2,729 | $0.46 | $1,243 | 364,574 | Sep 2, 2025 |
| Aug 31, 2025 | Christian Vasquez See Remarks | FTax withholding Common Stock | -1,566 | $0.46 | $713 | 283,564 | Sep 2, 2025 |
| Aug 31, 2025 | Jay M Short Phd Chief Executive Officer | FTax withholding Common Stock | -6,347 | $0.46 | $2,891 | 2,243,678 | Sep 2, 2025 |
| Jun 18, 2025 | Susan Moran director | AGrant or award Common Stock | +23,500 | $0.00 | $0 | 52,307 | Jun 18, 2025 |
| Jun 18, 2025 | Eddie Williams director | AGrant or award Common Stock | +23,500 | $0.00 | $0 | 60,200 | Jun 18, 2025 |
| Jun 18, 2025 | Lawrence Steinman director | AGrant or award Common Stock | +23,500 | $0.00 | $0 | 78,459 | Jun 18, 2025 |
| Jun 18, 2025 | Mary Ann Gray director | AGrant or award Common Stock | +23,500 | $0.00 | $0 | 77,397 | Jun 18, 2025 |
| Jun 18, 2025 | Sylvia McBrinn director | AGrant or award Common Stock | +23,500 | $0.00 | $0 | 59,125 | Jun 18, 2025 |
| Jun 18, 2025 | Scott Andrew Smith director | AGrant or award Common Stock | +23,500 | $0.00 | $0 | 321,550 | Jun 18, 2025 |
| May 31, 2025 | Christian Vasquez See Remarks | FTax withholding Common Stock | -1,566 | $0.41 | $640 | 285,130 | Jun 3, 2025 |
| May 31, 2025 | Eric Sievers Chief Medical Officer | FTax withholding Common Stock | -2,729 | $0.41 | $1,116 | 367,303 | Jun 3, 2025 |
| May 31, 2025 | Richard A Waldron Chief Financial Officer | FTax withholding Common Stock | -2,371 | $0.41 | $970 | 340,892 | Jun 3, 2025 |
| May 31, 2025 | Jay M Short Phd Chief Executive Officer | FTax withholding Common Stock | -6,347 | $0.41 | $2,596 | 2,250,025 | Jun 3, 2025 |
| Mar 12, 2025 | Jay M Short Phd Chief Executive Officer | AGrant or award Common Stock | +431,000 | $0.00 | $0 | 2,256,372 | Mar 13, 2025 |
| Mar 11, 2025 | Eric Sievers Chief Medical Officer | AGrant or award Common Stock | +175,000 | $0.00 | $0 | 370,032 | Mar 13, 2025 |
| Mar 11, 2025 | Richard A Waldron Chief Financial Officer | AGrant or award Common Stock | +100,000 | $0.00 | $0 | 333,263 | Mar 13, 2025 |
| Mar 11, 2025 | Christian Vasquez See Remarks | AGrant or award Common Stock | +85,000 | $0.00 | $0 | 276,696 | Mar 13, 2025 |
| Feb 16, 2025 | Jay M Short Phd Chief Executive Officer | FTax withholding Common Stock | -30,911 | $0.46 | $14k | 1,825,372 | Feb 24, 2025 |
| Feb 15, 2025 | Christian Vasquez See Remarks | FTax withholding Common Stock | -7,189 | $0.46 | $3,307 | 191,696 | Feb 24, 2025 |
| Feb 15, 2025 | Richard A Waldron Chief Financial Officer | FTax withholding Common Stock | -10,887 | $0.46 | $5,008 | 233,263 | Feb 24, 2025 |
| Feb 15, 2025 | Eric Sievers Chief Medical Officer | FTax withholding Common Stock | -12,530 | $0.46 | $5,764 | 195,032 | Feb 24, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Mary Ann Graydirector
- Sylvia McBrinndirector
- Susan Morandirector
- Jay M Short PhdChief Executive Officer
- Lawrence Steinmandirector
- Eric SieversChief Medical Officer
- Scott Andrew Smithdirector, ceo, officer
- Christian VasquezSee Remarks
- Richard A WaldronChief Financial Officer
- Eddie Williamsdirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.